UPMC CancerCenter - St. Margaret
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ellis, Peter
SUNRAY-01, NCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Recruiting
3
1016
Europe, Canada, Japan, US, RoW
LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed
Eli Lilly and Company, Loxo Oncology, Inc.
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
10/26
10/29
SCION, NCT04944173: SABR and Checkpoint Inhibition of NSCLC

Withdrawn
2
94
NA
Durvalumab, MEDI4736, Imfinzi, Stereotactic Body Radiotherapy, Stereotactic Radiation, Stereotactic Radiation Therapy, Circulating Tumor DNA assay, AVENIO ctDNA surveillance assay, MRD Landmark assay
University of British Columbia, AstraZeneca, Ozmosis Research Inc.
Non Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer Stage I, Lung Cancer, Lung Cancer Stage I, Lung Adenocarcinoma, Stage I, Lung Squamous Cell Carcinoma Stage I
12/26
06/27
CCTG IND.238A, NCT03847649: A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Recruiting
2
60
Canada
Durvalumab, Prednisone, Tremelimumab
Canadian Cancer Trials Group, AstraZeneca
Cancer
04/30
04/31
Sun, Min
NCT05649540: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

Active, not recruiting
4
900
RoW
Vonoprazan, Amoxicillin
Nanjing First Hospital, Nanjing Medical University
Helicobacter Pylori Infection
12/24
12/24
SAQ, NCT06547047: Speed, Agility, and Quickness Training

Not yet recruiting
N/A
52
RoW
Speed, Agility, and Quickness (SAQ) Training, Regular Training
SUN MIN
Speed, Agility, Quickness, Physical Performance
12/24
02/25
NCT01042548: Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

Recruiting
N/A
300
US
University of Pittsburgh, David Scaife Foundation
Breast Cancer
04/28
04/28
Liang, Hongmei
No trials found

Download Options